With his uncanny gift for shorting stocks and predicting the market, Martin Shkreli becomes a finance wunderkind almost right out of college. He experiments with hedge funds and eventually starts his own Pharma company, raising millions of dollars from high-profile investors. But when his Twitter antics and social media trolling begin to raise red flags, Martin’s reputation tanks. And after he price-gouges a life-saving drug, he goes from finance bro to the most hated man in America.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.